Susceptibilities of actinomyces species and propionibacterium propionicus to antimicrobial agents

Clinical Infectious Diseases

Volumn 25, Issue 2 SUPPL., 1997, Pages

  Tanaka Bandoh, Kaori ^b   Watanabe, Kunitomo ^a   Kato, Naoki ^b   Ueno, Kazue ^b  

^a GIFU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TOSUFLOXACIN;

ACTINOMYCES; ACTINOMYCES ISRAELII; ACTINOMYCES NAESLUNDII; ACTINOMYCOSIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONFERENCE PAPER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; PROPIONIBACTERIUM FREUDENREICHII SHERMANII;

ACTINOMYCES; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM;

EID: 0030769928     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516187     Document Type: Article

References (5)

1. Bandoh K, Ueno K, Watanabe K, Kalo N. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study. Clin Infect Dis 1993;16(suppl 4):S382-6.
2. Holmberg K, Nord CE, Dornbusch K. Antimicrobial in vitro susceptibility of Actinomyces israelii and Arachnid propionica. Scand J Infect Dis 1977;9:40-5.
3. Schaal KP. Genus Actinomyces. In: Sneath PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's manual of systematic bacteriology. Vol 2. Baltimore: Williams & Wilkins, 1986:1383-418.
4. Wade WG. In-vitro activity of ciprofloxacin and other agents against oral bacteria. J Antimicrob Chemother 1989;24:683-7.
5. Cullmann W, Frei R, Krech T. Antibacterial activity of oral antibiotics against anaerobic bacteria. Chemotherapy 1993;39:169-74.